JBIO compared with DMRA: revenue, margins and what each company keeps, and the suppliers and customers both name

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

DMRADamora Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

JBIOJade Biosciences, Inc.

DMRADamora Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only JBIO 3

—Patheon Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—WuXi Biologics Irelandunlistedsupplier

Shared 0

No shared counterparties.

Only DMRA 3

—Paragonunlistedsupplier

—Pre-Acquisition Damoraunlistedsupplier

—Bridge Medicinesunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

JBIOJade Biosciences, Inc.

14.07· pre 14.44· delayed

Mkt cap$885.9M

DMRADamora Therapeutics, Inc.

21.61· pre 21.61· delayed

Pre-marketNov 3 '26delayed

Mkt cap$1.3B

Compare

Pre-marketNov 3 '26delayed

JBIOJade Biosciences, Inc.

DMRADamora Therapeutics, Inc.

14.07pre 14.44delayed

Price

21.61pre 21.61delayed

$885.9M

Mkt cap

$1.3B

JBIO14.07vsDMRA21.61Pre-marketNov 3 '26delayed